ResMed (RMD)
(Delayed Data from NYSE)
$218.57 USD
-1.40 (-0.64%)
Updated May 17, 2024 04:00 PM ET
After-Market: $218.56 -0.01 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
RMD 218.57 -1.40(-0.64%)
Will RMD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for RMD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RMD
Haemonetics' (HAE) Hospital & Plasma Segments, Innovation Aid
Maravai (MRVI) Advances in RNA Research With New Collaboration
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Haemonetics (HAE) Stock Up 10.9% YTD: Will the Rally Continue?
What Makes ResMed (RMD) a New Strong Buy Stock
Align Technology (ALGN) Gains From Innovation, Global Expansion
Other News for RMD
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
Here are the biggest single-session post-results gains from the recent earnings season
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access
ResMed's MatrixCar partners with Health Gorilla